Friday, Aug 12, 2022

"dcgi-nod"

Hyderabad-based Optimus gets DCGI nod for molnupiravir phase III trials

The drug regulator gave nod for conducting the trial on mild and moderate Covid-19 patients
Dr Reddy’s gets DCGI nod for phase 3 trial for Sputnik V vaccine

The trial will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in India

Latest News